Thymosin alpha1 use in adult COVID-19 patients: A systematic review and meta-analysis on clinical outcomes

OBJECTIVE: Thymosin alpha1 (Ta1) is widely used to treat patients with coronavirus disease 2019 (COVID-19), however, its effect remains unclear. This systematic review and meta-analysis aimed to evaluate the effect of Ta1 as a COVID-19 therapy. METHODS: PubMed, EMBASE, the Cochrane library, Web of S...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Weifeng, Zhang, Bo, Ren, Yali, Wang, Weina, Zhou, Dengfeng, Li, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754924/
https://www.ncbi.nlm.nih.gov/pubmed/36527881
http://dx.doi.org/10.1016/j.intimp.2022.109584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754924/
https://www.ncbi.nlm.nih.gov/pubmed/36527881
http://dx.doi.org/10.1016/j.intimp.2022.109584

Ejemplares similares